United States · FDA National Drug Code directory
LANGLARA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 87682-090_55fe4d38-f4dd-bde7-e063-6394a90a44ba
- Product NDC
- 87682-090
- Form
- INJECTION, SOLUTION
- Composition / generic term
- insulin glargine-aldy
- Labeler
- Lanexa Biologics, LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260701
- Source listing expiry
- 20271231
Source-listed ingredients
- INSULIN GLARGINE — 100 [iU]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 SYRINGE in 1 CARTON (87682-090-05) / 3 mL in 1 SYRINGE (87682-090-01) · 87682-090-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →